drugset / Trial / NCT00529620

Three Alternative Drug Regimens for Malaria Seasonal Preventive Treatment in Senegal

NCT00529620

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this trial is to compare the acceptability, efficacy and safety of three alternative drug regimens for use for seasonal Intermittent Preventive Treatment to prevent malaria in children. Children aged 2 months to 5 years will be randomized to receive IPT with one of three regimens during the transmission season: sulfadoxine-pyrimethamine (SP) plus amodiaquine, show to be highly effective for IPT in a recent trial; SP plus piperaquine, used for malaria prophylaxis in China for many years; or Duocotexcin (a combination of piperaquine with an artemisinin).

Timeline

Start
2007-09
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator ARTENIMOL Small molecule
Comparator amodiaquine Other / unclassified
Comparator piperaquine Small molecule
Comparator sulfalene-pyrimethamine plus amodiaquine Unknown

Indications